Besifovir dipivoxil Uses, Dosage, Side Effects and more
Besifovir dipivoxil is a small-molecule orally available inhibitor of the HBV polymerase. The HBV polymerase is the enzyme that catalyzes the production of new RNA from the existing strand of RNA. Besifovir dipivoxil is believed to inhibit viral proliferation by interrupting the replicating machinery of the virus.
| Attribute | Details |
|---|---|
| Trade Name | Besifovir dipivoxil |
| Generic | Besifovir dipivoxil |
| Type | |
| Formula | C22H34N5O8P |
| Weight | Average: 527.515 Monoisotopic: 527.214500073 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hepatitis (viral, B).
How Besifovir dipivoxil works
Besifovir dipivoxil is an inhibitor of the HBV polymerase. It is believed to inhibit viral proliferation by interrupting the replicating machinery of the virus.
